TY - STD TI - World Health Organization Antimicrobial Resistance. Global Report on Surveillance 2014: WHO; 2014. https://www.who.int/drugresistance/documents/surveillancereport/en/. UR - https://www.who.int/drugresistance/documents/surveillancereport/en/ ID - ref1 ER - TY - JOUR AU - Paul, M. AU - Shani, V. AU - Muchtar, E. AU - Kariv, G. AU - Robenshtok, E. AU - Leibovici, L. PY - 2010 DA - 2010// TI - Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00627-10 DO - 10.1128/AAC.00627-10 ID - Paul2010 ER - TY - JOUR AU - Kumar, A. AU - Roberts, D. AU - Wood, K. E. PY - 2006 DA - 2006// TI - Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock JO - Crit Care Med VL - 34 UR - https://doi.org/10.1097/01.CCM.0000217961.75225.E9 DO - 10.1097/01.CCM.0000217961.75225.E9 ID - Kumar2006 ER - TY - JOUR AU - Harris, P. N. A. AU - Tambyah, P. A. AU - Lye, D. C. PY - 2018 DA - 2018// TI - Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E. coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: A randomized clinical trial JO - JAMA VL - 320 UR - https://doi.org/10.1001/jama.2018.12163 DO - 10.1001/jama.2018.12163 ID - Harris2018 ER - TY - JOUR AU - Daneman, N. i. c. k. AU - Fowler, R. o. b. e. r. t. A. PY - 2018 DA - 2018// TI - Shortening Antibiotic Treatment Durations for Bacteremia JO - Clinical Infectious Diseases VL - 69 UR - https://doi.org/10.1093/cid/ciy1057 DO - 10.1093/cid/ciy1057 ID - Daneman2018 ER - TY - JOUR AU - Havey, T. C. AU - Fowler, R. A. AU - Daneman, N. PY - 2011 DA - 2011// TI - Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis JO - Crit Care VL - 15 UR - https://doi.org/10.1186/cc10545 DO - 10.1186/cc10545 ID - Havey2011 ER - TY - JOUR AU - Daneman, N. AU - Shore, K. AU - Pinto, R. AU - Fowler, R. PY - 2011 DA - 2011// TI - Antibiotic treatment duration for bloodstream infections in critically ill patients: A national survey of Canadian infectious diseases and critical care specialists JO - Int J Antimicrob Agents VL - 38 UR - https://doi.org/10.1016/j.ijantimicag.2011.07.016 DO - 10.1016/j.ijantimicag.2011.07.016 ID - Daneman2011 ER - TY - JOUR AU - Daneman, N. AU - Rishu, A. H. AU - Xiong, W. PY - 2016 DA - 2016// TI - Duration of antimicrobial treatment for bacteremia in Canadian Critically ill patients JO - Crit Care Med VL - 44 UR - https://doi.org/10.1097/CCM.0000000000001393 DO - 10.1097/CCM.0000000000001393 ID - Daneman2016 ER - TY - JOUR AU - Daneman, N. AU - Rishu, A. H. AU - Pinto, R. PY - 2018 DA - 2018// TI - 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: A pilot randomized clinical trial JO - Trials VL - 19 UR - https://doi.org/10.1186/s13063-018-2474-1 DO - 10.1186/s13063-018-2474-1 ID - Daneman2018 ER - TY - JOUR AU - Daneman, N. AU - Rishu, A. H. AU - Xiong, W. PY - 2015 DA - 2015// TI - Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): study protocol for a pilot randomized controlled trial JO - Trials VL - 16 UR - https://doi.org/10.1186/s13063-015-0688-z DO - 10.1186/s13063-015-0688-z ID - Daneman2015 ER - TY - JOUR AU - Arnold, D. M. AU - Burns, K. E. AU - Adhikari, N. K. AU - Kho, M. E. AU - Meade, M. O. AU - Cook, D. J. PY - 2009 DA - 2009// TI - The design and interpretation of pilot trials in clinical research in critical care JO - Crit Care Med VL - 37 UR - https://doi.org/10.1097/CCM.0b013e3181920e33 DO - 10.1097/CCM.0b013e3181920e33 ID - Arnold2009 ER - TY - STD TI - Yahav D, Franceschini E, Koppel F, et al. Seven versus fourteen days of antibiotic therapy for uncomplicated Gram-negative bacteremia: A non-inferiority randomized controlled trial. Clin Infect Dis. 2019;69(7):1091–98. ID - ref12 ER - TY - JOUR AU - Chastre, J. AU - Wolff, M. AU - Fagon, J. Y. PY - 2003 DA - 2003// TI - Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial JO - JAMA VL - 290 UR - https://doi.org/10.1001/jama.290.19.2588 DO - 10.1001/jama.290.19.2588 ID - Chastre2003 ER - TY - JOUR AU - Sawyer, R. G. AU - Claridge, J. A. AU - Nathens, A. B. PY - 2015 DA - 2015// TI - Trial of short-course antimicrobial therapy for intraabdominal infection JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1411162 DO - 10.1056/NEJMoa1411162 ID - Sawyer2015 ER - TY - JOUR AU - Iversen, K. AU - Ihlemann, N. AU - Gill, S. U. PY - 2019 DA - 2019// TI - Partial oral versus intravenous antibiotic treatment of endocarditis JO - N Engl J Med VL - 380 UR - https://doi.org/10.1056/NEJMoa1808312 DO - 10.1056/NEJMoa1808312 ID - Iversen2019 ER - TY - STD TI - U.S.Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry Hospital-Acquired Bacterial Pneumonia and Ventilator Asssociated Bacterial Pneumonia: Developing Drugs for Treatment. 5-5-2014. Ref Type: Online Source. https://www.fda.gov/media/79516/download. UR - https://www.fda.gov/media/79516/download ID - ref16 ER -